Edwards Lifesciences Corp

NYSE:EW  
82.77
-1.06 (-1.26%)
Products

Edwards Launches Sapien 3 Ultra Resilia Valve Following FDA Approval

Published: 09/12/2022 14:02 GMT
Edwards Lifesciences Corp (EW) - Edwards Launches Sapien 3 Ultra Resilia Valve Following FDA Approval.
Edwards Lifesciences Corp - Sapien 3 Ultra Resilia Valve Will Be Available in U.S. in Limited Release in Q4 of 2022.
Edwards Lifesciences Corp - Commercial Opportunity Related to Approval is Factored Into 2022 Financial Expectations.